Cargando…

Anakinra in COVID-19: important considerations for clinical trials

Detalles Bibliográficos
Autores principales:	King, Andrew, Vail, Andy, O'Leary, Claire, Hannan, Cathal, Brough, David, Patel, Hiren, Galea, James, Ogungbenro, Kayode, Wright, Megan, Pathmanaban, Omar, Hulme, Sharon, Allan, Stuart
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241987/ https://www.ncbi.nlm.nih.gov/pubmed/32835233 http://dx.doi.org/10.1016/S2665-9913(20)30160-0

Ejemplares similares

Value of dynamic clinical and biomarker data for mortality risk prediction in COVID-19: a multicentre retrospective cohort study
por: Berzuini, Carlo, et al.
Publicado: (2020)

Intravenous anakinra can achieve experimentally effective concentrations in the central nervous system within a therapeutic time window: results of a dose-ranging study
por: Galea, James, et al.
Publicado: (2011)

The inflammatory microenvironment in vestibular schwannoma
por: Hannan, Cathal John, et al.
Publicado: (2020)

Cerebrospinal fluid and plasma cytokines after subarachnoid haemorrhage: CSF interleukin-6 may be an early marker of infection
por: Hopkins, Stephen J, et al.
Publicado: (2012)

Anakinra for patients with COVID-19
por: Maoujoud, Omar, et al.
Publicado: (2020)

The spatial phenotype of genotypically distinct meningiomas demonstrate potential implications of the embryology of the meninges
por: Fountain, Daniel M., et al.
Publicado: (2020)

Correction: The spatial phenotype of genotypically distinct meningiomas demonstrate potential implications of the embryology of the meninges
por: Fountain, Daniel M., et al.
Publicado: (2021)

Outcome after severe head injury: focal surgical lesions do not imply a better Glasgow Outcome Score than diffuse injuries at 3 months
por: Leach, Paul, et al.
Publicado: (2009)

Anakinra for patients with COVID-19
por: Valette, Xavier, et al.
Publicado: (2020)

Anakinra for patients with COVID-19
por: Martin-Silva, Nicolas, et al.
Publicado: (2020)

Effect of anakinra in COVID-19
por: Kooistra, Emma J, et al.
Publicado: (2020)

Anakinra: Jaundice: case report
Publicado: (2021)

Continuous IV infusion of anakinra
por: Saunders, Brittney N., et al.
Publicado: (2023)

The effect of intravenous interleukin-1 receptor antagonist on inflammatory mediators in cerebrospinal fluid after subarachnoid haemorrhage: a phase II randomised controlled trial
por: Singh, Navneet, et al.
Publicado: (2014)

Predicting survival of pancreatic cancer patients treated with gemcitabine using longitudinal tumour size data
por: Wendling, Thierry, et al.
Publicado: (2016)

Refractory Sweet Syndrome Treated with Anakinra
por: Shahid, Zainab, et al.
Publicado: (2019)

Cerebral autoinflammatory disease treated with anakinra
por: Jang, Yoonhyuk, et al.
Publicado: (2018)

Anakinra for severe forms of COVID-19
por: Laine, Marc, et al.
Publicado: (2020)

Anakinra for severe forms of COVID-19
por: Khan, Adil Rashid, et al.
Publicado: (2020)

Anakinra for severe forms of COVID-19
por: Khan, Naim Akhtar
Publicado: (2020)

Intravenous anakinra for cytokine storm syndromes
por: Jamilloux, Yvan, et al.
Publicado: (2020)

Anakinra in children and adults with Still’s disease
por: Vastert, Sebastiaan J, et al.
Publicado: (2019)

Anakinra in pediatric acute fulminant myocarditis
por: Maunier, Louise, et al.
Publicado: (2022)

The clinical, genetic, and immune landscape of meningioma in patients with NF2-schwannomatosis
por: Gregory, Grace E, et al.
Publicado: (2023)

Economic evaluation of a collaborative model of pharmaceutical care in an Irish hospital: cost-utility analysis
por: Kirwan, Gráinne, et al.
Publicado: (2023)

Considerations for chest clearance and cough augmentation in severe bulbar dysfunction: a case study
por: Allen, Jodi Elizabeth, et al.
Publicado: (2018)

Telephone Consultation as a Substitute for Routine Out-patient Face-to-face Consultation for Children With Inflammatory Bowel Disease: Randomised Controlled Trial and Economic Evaluation
por: Akobeng, Anthony K., et al.
Publicado: (2015)

Which factors influence decisions to transfer and treat patients with acute intracerebral haemorrhage and which are associated with prognosis? A retrospective cohort study
por: Abid, Kamran A, et al.
Publicado: (2013)

Effect of anakinra on arthropathy in CINCA/NOMID syndrome
por: Miyamae, Takako, et al.
Publicado: (2010)

Anakinra Therapy for Non-cancer Inflammatory Diseases
por: Cavalli, Giulio, et al.
Publicado: (2018)

Anakinra for Recurrent Fevers in Systemic Lupus Erythematosus
por: Dein, Eric, et al.
Publicado: (2018)

Schnitzler Syndrome: A Dramatic Response to Anakinra
por: Gouveia, Ana Isabel, et al.
Publicado: (2016)

Anakinra: a silver lining in COVID-19?
por: Gupta, Rahul
Publicado: (2020)

Anakinra for patients with COVID-19 – Authors' reply
por: Cavalli, Giulio, et al.
Publicado: (2020)

Effect of anakinra in COVID-19 – Authors' reply
por: Cavalli, Giulio, et al.
Publicado: (2020)

Anakinra treatment for refractory cerebral autoinflammatory responses
por: Jang, Yoonhyuk, et al.
Publicado: (2022)

Anakinra/steroids: Cytomegalovirus viremia: case report
Publicado: (2022)

Efficacy of Anakinra in Pericarditis: A Systematic Review
por: Cheema, Ameer Haider, et al.
Publicado: (2022)

Current evidence on the use of anakinra in COVID-19
por: Khani, Elnaz, et al.
Publicado: (2022)

Efficacy of anakinra on rebound of multisystem inflammatory syndrome
por: Brisca, Giacomo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7nsih02c9ocop0glahr6nunqvg